4//SEC Filing
KING EDMUND 4
Accession 0001181431-12-013884
CIK 0001310094other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:39 PM ET
Size
5.3 KB
Accession
0001181431-12-013884
Insider Transaction Report
Form 4
KING EDMUND
Director
Transactions
- Award
Stock Option (Right to Buy)
2012-02-29+100,000→ 100,000 totalExercise: $0.44From: 2012-02-29Exp: 2022-03-01→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Exercise price is 100% of fair market value on date of grant.
- [F2]The options vested immediately on the date of grant.
- [F3]The options terminate 10 years from the grant date, or 90 days after the non-employee director ceases to be a director for any reason, other than death, disability or retirement.
Documents
Issuer
ACCENTIA BIOPHARMACEUTICALS INC
CIK 0001310094
Entity typeother
Related Parties
1- filerCIK 0001198425
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:39 PM ET
- Size
- 5.3 KB